We are live on
!
Find out more
BWP
Barlow Wealth Partners Portfolio holdings
AUM
$926M
1-Year Est. Return
20.71%
This Fund
S&P 500
This Quarter
Est. Return
+4.37%
1 Year Est. Return
+20.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$790M
AUM Growth
+$25.3M
(+3.3%)
Cap. Flow
-$19.3M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
39.45%
Holding
155
New
8
Increased
46
Reduced
41
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nice
NICE
|
+$16.5M |
| 2 |
ASML
ASML
|
+$13M |
| 3 |
Houlihan Lokey
HLI
|
+$3.75M |
| 4 |
Pinnacle Financial Partners Inc
PNFP
|
+$2.97M |
| 5 |
Visa
V
|
+$1.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$18.5M |
| 2 |
CNR
Core Natural Resources Inc
CNR
|
+$15.4M |
| 3 |
Elevance Health
ELV
|
+$10.5M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$8.44M |
| 5 |
T. Rowe Price
TROW
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Financials | 21.79% |
| 3 | Communication Services | 10.73% |
| 4 | Industrials | 9.07% |
| 5 | Healthcare | 8.09% |
Similar funds
ICM
TC
CFA
MHIC
OWIM
VCAM
GFG
WC
Barlow Wealth Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Barlow Wealth Partners held 155 positions worth $790M, up 3.3% from $765M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barlow Wealth Partners's Q4 2024 filing shows 8 new, 46 increased, 41 reduced and 19 closed positions. Its largest new stake was Nice: 92,449 shares worth $15.5M. The largest sale was AstraZeneca, an estimated $18.5M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 24% a quarter earlier, followed by Financials and Communication Services.
- Barlow Wealth Partners's largest Q4 2024 buy was Nice: 92,449 shares worth $15.5M.
- Barlow Wealth Partners added most to Houlihan Lokey in Q4 2024, an estimated $3.75M increase.
- Barlow Wealth Partners's biggest Q4 2024 reduction was Elevance Health, cutting an estimated $10.5M.
- Barlow Wealth Partners fully exited AstraZeneca in Q4 2024, selling an estimated $18.5M.
- Barlow Wealth Partners's ten largest holdings make up 39% of its $790M portfolio in Q4 2024.
- Barlow Wealth Partners opened 8 new positions and closed 19 in Q4 2024.
- Barlow Wealth Partners's portfolio value rose 3.3% quarter-over-quarter to $790M.
Based on Barlow Wealth Partners's 13F filing for Q4 2024, filed 17 Jan 2025.